ArticleJournal of medical and biological engineering2025
Biomechanical effects of defect size and location on vertebral fracture.
Article in Journal of medical and biological engineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Purpose: Investigating the effect of metastatic lesions on the load-bearing capacity of the spinal column is essential for identifying appropriate interventions for patients. Most studies on the effects of tumor size and location on vertebral fractures are computational, with limited experimental data available. Furthermore, it remains unclear which parameters are most critical for assessing fracture risk in metastatic spines. The purpose of the current study was to investigate the effect of lesion size and location on fracture characteristics of the vertebral body and to find contributing factors associated with vertebral fractures. Methods: Human cadaveric spine segments were dissected from fresh frozen torsos and divided into three groups: intact, central defects affecting only trabecular bones, and anterior defects affecting both cortical and trabecular bones. Computed tomography imaging was performed to measure the geometry and Hounsfield Unit (HU) values and then, these specimens were mechanically tested to failure to record vertebral fracture forces. Results: Compared to the intact specimens (2092 kPa), the average fracture strength in the defect groups were reduced by at least 750 kPa with a defect size as small as 25% of the cross-sectional area (CSA) or 9% of the volume (p=0.0097). Tumor location did not significantly affect vertebral fracture forces (p=0.77), as both locations primarily involved trabecular bone. Conclusion: The results of this study suggest that the vertebral body becomes significantly weaker even with simulated lytic defects involving as little as approximately 9% of the vertebral volume or 25% of the vertebral cross-sectional area (CSA). This degree of bone involvement may represent a new biomechanical threshold for assessing fracture risk in metastatic spines with bone loss. These findings underscore the importance of proactive assessment and potential early intervention in patients with small vertebral lytic lesions-particularly in individuals already at elevated risk of vertebral fracture due to conditions such as osteoporosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.